Canadian Regulatory Guide

Are Peptides Legal in Canada?

A clear, comprehensive breakdown of the regulatory landscape surrounding research peptides in Canada. What Health Canada says, what WADA bans, and what researchers need to know.

The Short Answer

The legal status of peptides in Canada depends entirely on the specific peptide, its intended use, and how it is marketed. There is no single blanket classification that covers all peptides. Some are fully approved prescription medications (like Semaglutide), some are in active clinical trials and not yet available (like Retatrutide), some can be obtained through compounding pharmacies with a prescription (like Sermorelin), and many exist in a regulatory grey area as "research chemicals."

It is legal to purchase research-grade peptides in Canada for legitimate research purposes. It is not legal to market, sell, or advertise peptides as drugs, health products, or dietary supplements unless they have been specifically approved by Health Canada.

Health Canada's Regulatory Framework

Health Canada regulates health products through several frameworks, and different peptides may fall under different categories:

1. Prescription Drugs (Drug Identification Number — DIN)

Some peptides are fully approved prescription medications in Canada. These have undergone the complete regulatory review process, including clinical trials demonstrating safety and efficacy. They can only be obtained with a prescription from a licensed healthcare provider and dispensed by a licensed pharmacy. Examples include:

  • Semaglutide (Ozempic®, Wegovy®, Rybelsus®) — for diabetes and weight management
  • Bremelanotide/PT-141 (Vyleesi®) — for hypoactive sexual desire disorder
  • Insulin analogues — for diabetes management

2. Compounded Medications

Certain peptides, while not commercially available as branded products, can be legally prescribed by physicians and prepared by licensed compounding pharmacies in Canada. This applies to peptides that have an established safety history, such as:

  • Sermorelin — formerly FDA-approved, available through Canadian compounding pharmacies

Compounded medications are prepared according to a physician's prescription and are subject to provincial pharmacy regulations. They do not carry a DIN.

3. Natural Health Products (NHPs)

Some basic peptide compounds (like collagen peptides or certain amino acid complexes) may be regulated as Natural Health Products, requiring a Natural Product Number (NPN). These are not the research peptides discussed on this site.

4. Research Chemicals

The majority of peptides discussed on this site (BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Melanotan II, AOD-9604) are available through Canadian research chemical suppliers. These products are sold under the premise that they are for in-vitro research, laboratory use, or academic investigation only.

Key points about research chemicals in Canada:

  • They are not illegal to purchase for research purposes
  • They cannot be marketed as drugs, supplements, or health products
  • They have no regulatory oversight regarding purity, potency, or sterility
  • They are not approved for human consumption or therapeutic use
  • Suppliers cannot make health or therapeutic claims about them

WADA and Competitive Sports

The World Anti-Doping Agency (WADA) maintains its own prohibited list that applies to athletes competing in WADA-affiliated sports. This list is separate from Health Canada's regulatory framework. Key peptide prohibitions include:

  • BPC-157 — banned since 2022 under S0 (Non-Approved Substances)
  • TB-500 (Thymosin Beta-4) — banned under S0
  • All Growth Hormone Releasing Factors (including CJC-1295, Sermorelin, Ipamorelin) — banned under S2
  • All Growth Hormone Releasing Peptides — banned under S2
  • GLP-1 receptor agonists are currently not on the Prohibited List

Canadian athletes competing in sports governed by the Canadian Centre for Ethics in Sport (CCES) are subject to the WADA code. Violations can result in multi-year bans from competition.

Importing Peptides into Canada

Health Canada's Personal Importation Policy allows individuals to import certain medications not available in Canada for personal use, under specific conditions. However, this policy is designed for legitimate prescription medications from foreign jurisdictions, not for research chemicals.

In practice, many research peptides are available from Canadian-based suppliers, eliminating the need for cross-border importation. For peptides ordered from international suppliers, the Canada Border Services Agency (CBSA) may inspect shipments. Products that appear to be marketed for human consumption may be seized.

Health Canada Advisories

Health Canada has issued specific advisories about certain peptides, warning consumers about potential health risks:

  • Melanotan II: Health Canada has warned about unauthorized products containing Melanotan II, citing unknown safety risks
  • Selective Androgen Receptor Modulators (SARMs): While not peptides, these are often sold through similar channels, and Health Canada has issued multiple warnings

The Compounding Pharmacy Pathway

For Canadians seeking access to certain peptides under medical supervision, compounding pharmacies represent the most regulated pathway. A licensed physician can:

  • Assess whether a specific peptide is appropriate for the patient
  • Write a prescription for a compounding pharmacy to prepare
  • Monitor the patient during use
  • Ensure pharmaceutical-grade quality through a regulated pharmacy

This option is primarily available for peptides with established clinical histories, like Sermorelin. It is not available for newer research peptides like BPC-157 or TB-500.

Key Takeaways for Canadian Researchers

  • Research peptides are not illegal to purchase in Canada for legitimate research purposes
  • No research peptides should be marketed as drugs, supplements, or therapeutic products without Health Canada approval
  • Quality is unregulated in the research chemical market — always demand third-party testing
  • Some peptides are fully approved drugs (Semaglutide, PT-141/Bremelanotide) available through standard medical channels
  • WADA bans many peptides for competitive athletes — check the current Prohibited List
  • Compounding pharmacies offer a regulated pathway for certain peptides with physician prescriptions

Research Disclaimer

The information presented on this page is for educational and research purposes only. This content does not constitute medical advice, diagnosis, or treatment recommendations. The compounds discussed are investigational and, unless otherwise noted, have not been approved for human therapeutic use by Health Canada or any other regulatory body. Always consult a qualified healthcare professional before considering any new treatment or substance.

Looking for Research-Grade Peptides?

HCR Health provides high-purity, third-party tested research peptides for the Canadian market.

Browse Products at HCR Health